Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show

Tafenoquine, a prodrug that could fulfill the criteria for a mass eradication campaign.

University of Oxford’s online therapies offer hope for anxiety and PTSD patients

Urgent treatment solutions are needed for children, adolescents and adults with mental health conditions. Despite the government committing to spending 8.9% of all NHS funding

August 5, 2024

Leaky Blood Vessels and Long COVID; BCG Vaccine and Alzheimer’s; New CTE Subtype

Brain fog in long COVID may be due to a leaky blood-brain barrier, new research suggested. (Nature Neuroscience) A highly accurate novel blood test was

February 28, 2024

Jazz Pharma’s Enrylaze wins European approval for AML and LBL – Pharmaceutical Technology

A 3D illustration showing abundant lymphoblasts in blood. Enrylaze, sold as RylaZe in the US and Canada, was approved by the US Food and Drug

September 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.